Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.

Zhao SH, Wang Y, Wen L, Zhai ZB, Ai ZH, Yao NL, Wang L, Liu WC, Chen BL, Li Y, Yang H.

J Transl Med. 2013 Apr 8;11:92. doi: 10.1186/1479-5876-11-92.

2.

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.

Wen N, Wang Y, Wen L, Zhao SH, Ai ZH, Wang Y, Wu B, Lu HX, Yang H, Liu WC, Li Y.

J Transl Med. 2014 May 20;12:134. doi: 10.1186/1479-5876-12-134.

3.

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer.

Su D, Xu H, Feng J, Gao Y, Gu L, Ying L, Katsaros D, Yu H, Xu S, Qi M.

J Transl Med. 2012 Feb 27;10:31. doi: 10.1186/1479-5876-10-31.

4.

High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.

Zuo P, Ma Y, Huang Y, Ye F, Wang P, Wang X, Zhou C, Lu W, Kong B, Xie X.

Gynecol Oncol. 2014 Mar;132(3):745-51. doi: 10.1016/j.ygyno.2014.01.044. Epub 2014 Jan 31.

PMID:
24486602
5.

Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.

Zhou S, Tang L, Wang H, Dai J, Zhang J, Shen L, Ng SW, Berkowitz RS.

Gynecol Oncol. 2013 Oct;131(1):69-76. doi: 10.1016/j.ygyno.2013.06.031. Epub 2013 Jun 29.

PMID:
23820113
6.

Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.

Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, Zhang Y, Li Q, Hua KQ.

Gynecol Oncol. 2014 Jul;134(1):121-8. doi: 10.1016/j.ygyno.2014.03.556. Epub 2014 Mar 22.

PMID:
24662839
7.

The role of EMMPRIN expression in ovarian epithelial carcinomas.

Zhao Y, Chen S, Gou WF, Niu ZF, Zhao S, Xiao LJ, Takano Y, Zheng HC.

Cell Cycle. 2013 Sep 1;12(17):2899-913. doi: 10.4161/cc.25950. Epub 2013 Aug 8.

8.

Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.

Yang S, Li H, Liu Y, Ning X, Meng F, Xiao M, Wang D, Lou G, Zhang Y.

Med Oncol. 2013 Mar;30(1):324. doi: 10.1007/s12032-012-0324-7. Epub 2012 Dec 18.

PMID:
23254963
9.

Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.

Hou T, Yang C, Tong C, Zhang H, Xiao J, Li J.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):280-7. eCollection 2014.

10.

High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer.

Zhang J, Tang L, Shen L, Zhou S, Duan Z, Xiao L, Cao Y, Mu X, Zha L, Wang H.

Gynecol Oncol. 2012 Oct;127(1):223-30. doi: 10.1016/j.ygyno.2012.06.008. Epub 2012 Jun 18.

PMID:
22721732
11.

The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.

Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.

Gynecol Oncol. 2006 Dec;103(3):831-40. Epub 2006 Aug 17.

PMID:
16919315
12.

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.

Peng DX, Luo M, Qiu LW, He YL, Wang XF.

Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11.

13.

Functional role and prognostic significance of CD157 in ovarian carcinoma.

Ortolan E, Arisio R, Morone S, Bovino P, Lo-Buono N, Nacci G, Parrotta R, Katsaros D, Rapa I, Migliaretti G, Ferrero E, Volante M, Funaro A.

J Natl Cancer Inst. 2010 Aug 4;102(15):1160-77. doi: 10.1093/jnci/djq256. Epub 2010 Jul 16.

PMID:
20639476
14.

Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.

Zhao F, Siu MK, Jiang L, Tam KF, Ngan HY, Le XF, Wong OG, Wong ES, Chan HY, Cheung AN.

Histopathology. 2011 Dec;59(6):1163-72. doi: 10.1111/j.1365-2559.2011.04045.x.

PMID:
22175896
15.

High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.

Kim HJ, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG.

Eur J Cancer. 2012 Aug;48(12):1914-21. doi: 10.1016/j.ejca.2012.02.005. Epub 2012 Mar 2.

PMID:
22386573
16.

CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.

Li T, Xue H, Guo Y, Guo K.

Oncol Rep. 2014 Apr;31(4):1825-31. doi: 10.3892/or.2014.3045. Epub 2014 Feb 20.

PMID:
24573179
17.

Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer.

Song T, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.

Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28.

PMID:
22285843
18.

Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.

Zhang J, Tang L, Chen Y, Duan Z, Xiao L, Li W, Liu X, Shen L.

Hum Pathol. 2015 Sep;46(9):1331-40. doi: 10.1016/j.humpath.2015.05.015. Epub 2015 May 30.

PMID:
26193797
19.

Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer.

Bao X, Zhao S, Liu T, Liu Y, Liu Y, Yang X.

J Histochem Cytochem. 2013 Mar;61(3):206-17. doi: 10.1369/0022155413475452. Epub 2013 Jan 4.

20.

[Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].

Huang M, Wang Q, Zhang W, Li DR, Li L.

Zhonghua Fu Chan Ke Za Zhi. 2013 Jan;48(1):34-40. Chinese.

PMID:
23531249

Supplemental Content

Support Center